Analyze Diet
PloS one2016; 11(10); e0164049; doi: 10.1371/journal.pone.0164049

In Vitro and In Vivo Development of Horse Cloned Embryos Generated with iPSCs, Mesenchymal Stromal Cells and Fetal or Adult Fibroblasts as Nuclear Donors.

Abstract: The demand for equine cloning as a tool to preserve high genetic value is growing worldwide; however, nuclear transfer efficiency is still very low. To address this issue, we first evaluated the effects of time from cell fusion to activation (<1h, n = 1261; 1-2h, n = 1773; 2-3h, n = 1647) on in vitro and in vivo development of equine embryos generated by cloning. Then, we evaluated the effects of using different nuclear donor cell types in two successive experiments: I) induced pluripotent stem cells (iPSCs) vs. adult fibroblasts (AF) fused to ooplasts injected with the pluripotency-inducing genes OCT4, SOX2, MYC and KLF4, vs. AF alone as controls; II) umbilical cord-derived mesenchymal stromal cells (UC-MSCs) vs. fetal fibroblasts derived from an unborn cloned foetus (FF) vs. AF from the original individual. In the first experiment, both blastocyst production and pregnancy rates were higher in the 2-3h group (11.5% and 9.5%, respectively), respect to <1h (5.2% and 2%, respectively) and 1-2h (5.6% and 4.7%, respectively) groups (P<0.05). However, percentages of born foals/pregnancies were similar when intervals of 2-3h (35.2%) or 1-2h (35.7%) were used. In contrast to AF, the iPSCs did not generate any blastocyst-stage embryos. Moreover, injection of oocytes with the pluripotency-inducing genes did not improve blastocyst production nor pregnancy rates respect to AF controls. Finally, higher blastocyst production was obtained using UC-MSC (15.6%) than using FF (8.9%) or AF (9.3%), (P<0.05). Despite pregnancy rates were similar for these 3 groups (17.6%, 18.2% and 22%, respectively), viable foals (two) were obtained only by using FF. In summary, optimum blastocyst production rates can be obtained using a 2-3h interval between cell fusion and activation as well as using UC-MSCs as nuclear donors. Moreover, FF line can improve the efficiency of an inefficient AF line. Overall, 24 healthy foals were obtained from a total of 29 born foals.
Publication Date: 2016-10-12 PubMed ID: 27732616PubMed Central: PMC5061425DOI: 10.1371/journal.pone.0164049Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study investigates ways to improve the efficiency of cloning horses, exploring the impact of different timings from cell fusion to activation and using various types of cells as nuclear donors, including induced pluripotent stem cells and mesenchymal stromal cells. The researchers identified an optimum timing interval for cell fusion and activation and determined that using certain types of nuclear donors can enhance the production rate of blastocysts.

Experiment Design

The scientists conducted a series of tests to optimize the process of equine cloning. They began by assessing the effects of various time intervals from cell fusion to activation on horse embryos created through cloning. The timings under examination were less than 1 hour, 1-2 hours, and 2-3 hours. The next step involved evaluating the impact of using diverse types of nuclear donor cells in two chained experiments. The cells used were:

  • Induced pluripotent stem cells (iPSCs)
  • Adult fibroblasts (AF)
  • Ooplasts injected with pluripotency-inducing genes (OCT4, SOX2, MYC, and KLF4)
  • Umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
  • Fetal fibroblasts (FF) derived from an unborn cloned foetus

Results of Time Interval Test

According to the study, the success rate of both blastocyst production and pregnancy was highest for the 2-3 hours group. There were no significant differences in the number of foals born per pregnancy when the 2-3 hours and the 1-2 hours timespan were employed.

Results of Different Cell Types Test

During the testing of varying cell types, it was observed that iPSCs did not generate any embryos at the blastocyst stage, and that the injection of oocytes with pluripotency-inducing genes did not necessarily lead to higher rates of blastocyst production or pregnancy. However, the researchers found that the use of UC-MSCs resulted in a significantly higher blastocyst production compared to using FF or AF.

Conclusions Drawn

Following these experiments, the study concluded that optimal blastocyst production can be achieved by employing a 2-3-hour gap between cell fusion and activation. Additionally, utilizing UC-MSCs as nuclear donors significantly improved the efficiency of blastocyst production. The study also suggested that the FF line might be used to improve the efficacy of an otherwise inefficient AF line. In total, out of 29 foals born, 24 healthy foals were obtained, indicating the potential application of these strategies in boosting the efficiency of equine cloning.

Cite This Article

APA
Olivera R, Moro LN, Jordan R, Luzzani C, Miriuka S, Radrizzani M, Donadeu FX, Vichera G. (2016). In Vitro and In Vivo Development of Horse Cloned Embryos Generated with iPSCs, Mesenchymal Stromal Cells and Fetal or Adult Fibroblasts as Nuclear Donors. PLoS One, 11(10), e0164049. https://doi.org/10.1371/journal.pone.0164049

Publication

ISSN: 1932-6203
NlmUniqueID: 101285081
Country: United States
Language: English
Volume: 11
Issue: 10
Pages: e0164049
PII: e0164049

Researcher Affiliations

Olivera, Ramiro
  • KHEIRON S.A Laboratory, Pilar, Buenos Aires, Argentina.
Moro, Lucia Natalia
  • Laboratory of Biology of Cell Development, LIAN-Unit associated with CONICET, FLENI, Belen de Escobar, Buenos Aires, Argentina.
Jordan, Roberto
  • KHEIRON S.A Laboratory, Pilar, Buenos Aires, Argentina.
Luzzani, Carlos
  • Laboratory of Biology of Cell Development, LIAN-Unit associated with CONICET, FLENI, Belen de Escobar, Buenos Aires, Argentina.
Miriuka, Santiago
  • Laboratory of Biology of Cell Development, LIAN-Unit associated with CONICET, FLENI, Belen de Escobar, Buenos Aires, Argentina.
Radrizzani, Martin
  • Laboratory of Neruogenetic and Molecular Cytogentic, School of Sciences, National University of San Martin, CONICET, Buenos Aires, Argentina.
Donadeu, F Xavier
  • The Roslin Institute and Royal School of Veterinary Studies, University of Edinburgh, Easter Bush, Midlothian, United Kingdom.
  • Euan MacDonald Centre for MND Research, University of Edinburgh, Edinburgh, United Kingdom.
Vichera, Gabriel
  • KHEIRON S.A Laboratory, Pilar, Buenos Aires, Argentina.

MeSH Terms

  • Animals
  • Blastocyst / cytology
  • Cell Differentiation
  • Cell Lineage
  • Cell Nucleus / physiology
  • Cells, Cultured
  • Embryo Transfer
  • Female
  • Fetus / cytology
  • Fibroblasts / cytology
  • Horses
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / metabolism
  • Kruppel-Like Factor 4
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / metabolism
  • Microinjections
  • Nuclear Transfer Techniques
  • Oocytes / cytology
  • Plasmids / genetics
  • Plasmids / metabolism
  • Pregnancy
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Umbilical Cord / cytology

Conflict of Interest Statement

The authors have declared that no competing interests exist.

References

This article includes 63 references

Citations

This article has been cited 10 times.
  1. Suvá M, Arnold VH, Wiedenmann EA, Jordan R, Galvagno E, Martínez M, Vichera GD. First sex modification case in equine cloning.. PLoS One 2023;18(1):e0279869.
    doi: 10.1371/journal.pone.0279869pubmed: 36598913google scholar: lookup
  2. Yang XC, Wu XL, Li WH, Wu XJ, Shen QY, Li YX, Peng S, Hua JL. OCT6 inhibits differentiation of porcine-induced pluripotent stem cells through MAPK and PI3K signaling regulation.. Zool Res 2022 Nov 18;43(6):911-922.
  3. Yu B, van Tol HTA, Oei CHY, Stout TAE, Roelen BAJ. Lysophosphatidic Acid Accelerates Bovine In Vitro-Produced Blastocyst Formation through the Hippo/YAP Pathway.. Int J Mol Sci 2021 May 31;22(11).
    doi: 10.3390/ijms22115915pubmed: 34072880google scholar: lookup
  4. Lee AR, Park JH, Shim SH, Hong K, La H, Park KS, Lee DR. Genome stabilization by RAD51-stimulatory compound 1 enhances efficiency of somatic cell nuclear transfer-mediated reprogramming and full-term development of cloned mouse embryos.. Cell Prolif 2021 Jul;54(7):e13059.
    doi: 10.1111/cpr.13059pubmed: 34021643google scholar: lookup
  5. Hisey EA, Ross PJ, Meyers S. Genetic Manipulation of the Equine Oocyte and Embryo.. J Equine Vet Sci 2021 Apr;99:103394.
    doi: 10.1016/j.jevs.2021.103394pubmed: 33781418google scholar: lookup
  6. Moro LN, Viale DL, Bastón JI, Arnold V, Suvá M, Wiedenmann E, Olguín M, Miriuka S, Vichera G. Generation of myostatin edited horse embryos using CRISPR/Cas9 technology and somatic cell nuclear transfer.. Sci Rep 2020 Sep 24;10(1):15587.
    doi: 10.1038/s41598-020-72040-4pubmed: 32973188google scholar: lookup
  7. Pessôa LVF, Bressan FF, Freude KK. Induced pluripotent stem cells throughout the animal kingdom: Availability and applications.. World J Stem Cells 2019 Aug 26;11(8):491-505.
    doi: 10.4252/wjsc.v11.i8.491pubmed: 31523369google scholar: lookup
  8. Pessôa LVF, Pires PRL, Del Collado M, Pieri NCG, Recchia K, Souza AF, Perecin F, da Silveira JC, de Andrade AFC, Ambrosio CE, Bressan FF, Meirelles FV. Generation and miRNA Characterization of Equine Induced Pluripotent Stem Cells Derived from Fetal and Adult Multipotent Tissues.. Stem Cells Int 2019;2019:1393791.
    doi: 10.1155/2019/1393791pubmed: 31191664google scholar: lookup
  9. Moro LN, Amin G, Furmento V, Waisman A, Garate X, Neiman G, La Greca A, Santín Velazque NL, Luzzani C, Sevlever GE, Vichera G, Miriuka SG. MicroRNA characterization in equine induced pluripotent stem cells.. PLoS One 2018;13(12):e0207074.
    doi: 10.1371/journal.pone.0207074pubmed: 30507934google scholar: lookup
  10. Olivera R, Moro LN, Jordan R, Pallarols N, Guglielminetti A, Luzzani C, Miriuka SG, Vichera G. Bone marrow mesenchymal stem cells as nuclear donors improve viability and health of cloned horses.. Stem Cells Cloning 2018;11:13-22.
    doi: 10.2147/SCCAA.S151763pubmed: 29497320google scholar: lookup